Skip to content

Drug interactions

Ketamine + Larotrectinib

Severity: Minor

Ketamine and Larotrectinib: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Larotrectinib is a CYP3A4 substrate that is reported to inhibit CYP3A4 weakly, so ketamine levels may rise slightly. The expected clinical effect is small.

What this interaction means in plain words

Ketamine and Larotrectinib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Ketamine belongs to Central Nervous System; Larotrectinib belongs to Oncology.

Evidence level: Low

Why it happens

Possible weak CYP3A4 inhibition by larotrectinib reducing ketamine clearance.

What to do

No routine adjustment is needed; titrate ketamine to clinical response and observe for prolonged sedation.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Ketamine and Larotrectinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Ketamine with Larotrectinib?

MediHelp rates the interaction as minor. Ketamine and Larotrectinib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Larotrectinib is a CYP3A4 substrate that is reported to inhibit CYP3A4 weakly, so ketamine levels may rise slightly. The expected clinical effect is small.

How serious is the interaction between Ketamine and Larotrectinib?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine adjustment is needed; titrate ketamine to clinical response and observe for prolonged sedation.

What other medicines interact with Ketamine?

MediHelp also lists interactions of Ketamine with, for example, Benzhydrocodone / acetaminophen, Brexanolone, Buprenorphine buccal. The full list is on the Ketamine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in